Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
31.59
-0.18 (-0.57%)
Dec 5, 2025, 4:00 PM EST - Market closed
Galapagos NV Employees
Galapagos NV had 704 employees as of December 31, 2024. The number of employees decreased by 419 or -37.31% compared to the previous year.
Employees
704
Change (1Y)
-419
Growth (1Y)
-37.31%
Revenue / Employee
$478,186
Profits / Employee
-$726,568
Market Cap
2.07B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GLPG News
- 10 days ago - Galapagos Receives Transparency Notifications from Bank of America - GlobeNewsWire
- 4 weeks ago - Galapagos NV (GLPG) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Galapagos to Present New Data from Cell Therapy Program at ASH 2025 - GlobeNewsWire
- 6 weeks ago - Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors - GlobeNewsWire
- 6 weeks ago - Biotech firm Galapagos to wind down cell therapy business - Reuters
- 6 weeks ago - Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company's Ongoing Transformation - GlobeNewsWire
- 7 weeks ago - Galapagos Announces Appointment of Fred Blakeslee as General Counsel - GlobeNewsWire
- 2 months ago - Biotechnology firm Galapagos receives offers for cell-therapy business - Reuters